Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens

By LabMedica International staff writers
Posted on 20 Feb 2023

The global microbiology diagnostic devices and equipment market is expected to register a compound annual growth rate (CAGR) of 10.7% from USD 3.42 billion in 2021 to USD 5.69 billion in 2026 and grow further at a CAGR of 8.6% from 2026 to reach USD 8.56 billion in 2031. The market growth has been driven by increased healthcare expenditure, growth in the emerging markets, rapid technological advances, fast-paced increase in the aging population and the emergence of novel pathogenic infestations. However, regulatory challenges, political uncertainties, reduction in free trade and low healthcare reimbursements have negatively impacted market growth. Going forward, a rise in funding, growth in the aging population, enhanced healthcare access, and increase in various bacterial and viral epidemics will drive the growth of the global microbiology diagnostic devices and equipment market. However, the market growth could be hindered by a lack of skilled/trained microbiologists and insufficient and outdated health systems.

These are the latest findings of ResearchAndMarkets.com (Dublin, Ireland), a leading source for international market research reports and market data.

Based on type, the reagents and consumables market segment dominated the microbiology diagnostic devices and equipment market with the largest share of 80.6% in 2021 and is expected to register the fastest CAGR of 11.7% during the 2021-2026 forecast period. Based on type, the bacterial colony counters segment dominated the laboratory instruments market with the largest share of 24.8% in 2021 and is expected to register the fastest CAGR of 6.2% during the forecast period. Based on type, the microscopes segment dominated the microbiology analyzers market with the largest share of 56.1% in 2021 and is expected to register the fastest CAGR of 8.2% during the forecast period.

Based on type, the general reagents segment dominated the reagents and consumables market with the largest share of 60.5% in 2021. However, going forward, the pathogen-specific kits segment is expected to register the fastest CAGR of 14.6% during the forecast period. By end-user, the diagnostic laboratories segment dominated the microbiology diagnostic devices and equipment market with the largest share of 56.8% in 2021. However, going forward, the other end-users segment is expected to register the fastest CAGR of 10.9% during the forecast period.

Geographically, North America dominated the global microbiology diagnostic devices and equipment market with the largest share of 34.5% in 2021, followed by Asia Pacific and other regions. However, going forward, the microbiology diagnostic devices and equipment market in Africa and South America is expected to register the fastest CAGRs of 14.5% and 14.3%, respectively during the forecast period, followed by Eastern Europe and Middle East with CAGRs of 13.3% and 12.9%, respectively.

Related Links:
ResearchAndMarkets.com

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.